Dapagliflozin for Long COVID Syndrome
Clinical trial NCT06907251 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06907251
- Sponsor
- Ottawa Heart Institute Research Corporation
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-09-01
- Primary completion
- 2028-06-30
- Enrollment
- 192
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.